FDA.report

Application 076543

Type
ANDA
Sponsor
TARO

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001BETAMETHASONE DIPROPIONATEBETAMETHASONE DIPROPIONATECREAM, AUGMENTED;TOPICALEQ 0.05% BASENoNo

NDC Listings For This Application

NDCNameNonproprietary nameLabelerMarketing categoryStatus
50090-5232Betamethasone DipropionateBetamethasone DipropionateA-S Medication SolutionsANDACurrent
50090-5232Betamethasone DipropionateBetamethasone DipropionateA-S Medication SolutionsANDACurrent
50090-5232Betamethasone DipropionateBetamethasone DipropionateA-S Medication SolutionsANDACurrent
51672-1310Betamethasone DipropionateBetamethasone DipropionateTaro Pharmaceuticals U.S.A., Inc.ANDACurrent
51672-1310Betamethasone DipropionateBetamethasone DipropionateTaro Pharmaceuticals U.S.A., Inc.ANDACurrent
51672-1310Betamethasone DipropionateBetamethasone DipropionateTaro Pharmaceuticals U.S.A., Inc.ANDACurrent
68071-4556Betamethasone DipropionateBetamethasone DipropionateNuCare Pharmaceuticals,Inc.ANDACurrent
68071-4556Betamethasone DipropionateBetamethasone DipropionateNuCare Pharmaceuticals,Inc.ANDACurrent
68071-4556Betamethasone DipropionateBetamethasone DipropionateNuCare Pharmaceuticals,Inc.ANDACurrent
68788-7670Betamethasone DipropionateBetamethasone DipropionatePreferred Pharmaceuticals, Inc.ANDACurrent
68788-7670Betamethasone DipropionateBetamethasone DipropionatePreferred Pharmaceuticals, Inc.ANDACurrent
68788-7670Betamethasone DipropionateBetamethasone DipropionatePreferred Pharmaceuticals, Inc.ANDACurrent